Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk than insulin
byHarvard T.H. Chan School of Public HealthCredit: CC0 Public DomainInfants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) du
Updated on: January 13,2024
5

Prenatal exposure to GLP-1 receptor agonists and other second-line antidiabetics may not pose greater risk than insulin
byHarvard T.H. Chan School of Public HealthCredit: CC0 Public DomainInfants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) du
Updated on:January 13,2024
5
